64 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
20 Apr 22
Additional proxy soliciting materials
4:30pm
Base Salary Annual Incentive (Paid in cash) Allows us to attract and retain talent in a highly competitive labor market Based on specialized … Management (50%) Retain and develop critical talent to support our strategy and deliver on merger priorities Synergies (50%) Reflects commitment to deliver
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
for the future.”
Samuels added, “Together with Giovanni, our Board of Directors has been engaged in thoughtful, ongoing succession planning and talent … new medicines. He has helped build a deep bench of commercial talent as well as industry-leading market access capabilities. These efforts have been
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Compensation Program Looking Forward: 2024 Compensation Program* Base Salary Annual Incentive (Paid in cash) Allows us to attract and retain talent … on sustainability and social impact Important component of attracting specialized talent Rewards creation of incremental shareholder value Provides a mix of short
SC TO-C
BMY
Bristol-Myers Squibb Co.
8 Sep 10
Information about tender offer
12:00am
of product assets, talent and scientific capabilities we are looking for in our String of Pearl strategy.
Over the next several weeks as we work … to close our deal with ZymoGenetics, we will decide how to specifically integrate ZymoGenetics’ talent, pipeline and commercial assets into our company
DEFA14A
BMY
Bristol-Myers Squibb Co.
26 Apr 23
Additional proxy soliciting materials
4:38pm
.”
Samuels added, “Together with Giovanni, our Board of Directors has been engaged in thoughtful, ongoing succession planning and talent development … has helped build a deep bench of commercial talent as well as industry-leading market access capabilities. These efforts have been vital to helping us
8-K
EX-99.1
00s3ys
23 Jul 18
Bristol-Myers Squibb Announces Departure of Chief Commercial Officer
4:34pm
8-K
EX-99.1
u86 18yms2hruh7whm
21 Oct 11
Bristol-Myers Squibb Announces Changes in Senior Management Team
12:00am
8-K
EX-99.1
9wcznmp22l7wu
22 Sep 05
Entry into a Material Definitive Agreement
12:00am
425
9qfc2xxu0a m3
31 Jan 19
Business combination disclosure
12:00am
DEFA14A
qnenxv ko7ok
19 Apr 21
Additional proxy soliciting materials
7:41am
425
7e6tz5
3 Jan 19
Business combination disclosure
5:26pm
8-K
EX-99.1
3yoyiii4c3pn2lr1t
20 Nov 19
Creating a Leading Biopharma Company
5:21pm
425
zlv8 261rphxc
19 Feb 19
Business combination disclosure
5:21pm
DEFA14A
843fut
10 Apr 23
Additional proxy soliciting materials
5:12pm